increased use of spironolactone for heart failure is causing more hospitalizations and deaths
September 2004
The increased use of spironolactone for heart failure is causing more hospitalizations and deaths.
The problem started a few years ago when a large well-respected Canadian study showed that spironolactone improved survival in patients with severe heart failure.
This was the Randomized Aldactone Evaluation Study (RALES).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive